First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
| dc.contributor.author | Bergh, J. | |
| dc.contributor.author | Bondarenko, I. | |
| dc.contributor.author | Lichinitser, M. | |
| dc.contributor.author | Liljegren, A. | |
| dc.contributor.author | Greil, R. | |
| dc.contributor.author | Voytko, N. | |
| dc.contributor.author | Makhson, A. | |
| dc.contributor.author | Cortes, J. | |
| dc.contributor.author | Lortholary, A. | |
| dc.contributor.author | Bischoff, J. | |
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | Delaloge, S. | |
| dc.contributor.author | Huang, X. | |
| dc.contributor.author | Kern, K. | |
| dc.contributor.author | Giorgetti, C. | |
| dc.date.accessioned | 2017-01-30T12:01:49Z | |
| dc.date.available | 2017-01-30T12:01:49Z | |
| dc.date.created | 2014-11-19T01:13:19Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Bergh, J. and Bondarenko, I. and Lichinitser, M. and Liljegren, A. and Greil, R. and Voytko, N. and Makhson, A. et al. 2012. First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study. Journal of Clinical Oncology. 30 (9): pp. 921-929. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/17432 | |
| dc.publisher | American Society of Clinical Oncology | |
| dc.title | First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study | |
| dc.type | Journal Article | |
| dcterms.source.volume | 30 | |
| dcterms.source.number | 9 | |
| dcterms.source.startPage | 921 | |
| dcterms.source.endPage | 929 | |
| dcterms.source.issn | 0732 183X | |
| dcterms.source.title | Journal of Clinical Oncology | |
| curtin.accessStatus | Fulltext not available |